🧩 Step 5 — Concept Integration
This section integrates development, structure, function, disease mechanisms, and treatment into a single conceptual pathway. Focus on understanding how one event leads to another.
🧭 Whole Topic Core Flow
Whole Topic Core Flow
Heart Pumping + Vascular Resistance + Blood Volume
↓
Maintain Normal Blood Pressure
↓
Baroreceptors + ANS + Kidneys + RAAS continuously regulate BP
↓
Failure of regulation
↓
↑ Sympathetic activity / ↑ RAAS / ↑ Peripheral resistance / ↑ Blood volume
↓
Hypertension
↓
Endothelial injury + Increased cardiac workload
↓
Stroke / LV hypertrophy / Kidney damage / Cardiovascular disease
↓
Drug Action:
• β-blockers → ↓ sympathetic effects
• ACE inhibitors → ↓ Angiotensin II
• Diuretics → ↓ blood volume
• Vasodilators → ↓ peripheral resistance
↓
Reduced BP + Reduced cardiovascular risk
⚙️ Core Mechanism Integration
Main Physiological Failure Mechanism
Persistent sympathetic activation or renal sodium retention
↓
↑ Peripheral vasoconstriction + ↑ Blood volume
↓
↑ Cardiac output and ↑ Total peripheral resistance
↓
Sustained elevation of arterial blood pressure
↓
Chronic vascular wall stress
↓
Endothelial dysfunction and arterial damage
↓
Reduced organ perfusion efficiency
↓
Heart, brain, kidney, and retinal complications
🩺 Clinical Integration Snapshot
A. Essential Hypertension
Increased sympathetic tone + RAAS overactivity
↓
Persistent vasoconstriction and sodium retention
↓
Chronic hypertension
↓
Headache, LV hypertrophy, vascular injury
↓
ACE inhibitors + Lifestyle modification
↓
Reduced BP and reduced cardiovascular risk
B. Hemorrhage and Hypotension
Blood loss
↓
↓ Venous return and ↓ cardiac output
↓
Hypotension
↓
Reduced cerebral perfusion
↓
Dizziness, fainting, shock
↓
Baroreceptor activation + IV fluid replacement
↓
Restoration of blood pressure
C. Renal Artery Stenosis
Reduced renal perfusion
↓
Excess renin release
↓
↑ Angiotensin II and aldosterone
↓
Vasoconstriction + water retention
↓
Secondary hypertension
↓
ACE inhibitors / ARBs
↓
Reduced RAAS-mediated BP elevation
🔥 Ultra–High–Yield Master Summary
NORMAL:
Heart + vessels + kidneys maintain BP through ANS and RAAS
DISEASE:
↑ Sympathetic activity / ↑ RAAS / ↑ resistance / ↑ blood volume
↓
Hypertension
OR
↓ Blood volume / ↓ cardiac output
↓
Hypotension
DRUG ACTION:
• β-blockers → ↓ cardiac stimulation
• ACE inhibitors → ↓ Angiotensin II
• Diuretics → ↓ blood volume
• Vasodilators → ↓ resistance
RESULT:
Improved tissue perfusion + reduced cardiovascular complications
SYSTEM THINKING SUMMARY
• Heart determines flow
• Vessels determine resistance
• Kidneys determine volume
• ANS controls rapid changes
• RAAS controls long-term balance
• Failure of regulation produces hypertension or hypotension
• Treatment targets the failed control mechanism
